PLAY PODCASTS
News Explained: Why did the Indian Patent Office reject J&J’s application to extend its patent on an anti-TB drug?

News Explained: Why did the Indian Patent Office reject J&J’s application to extend its patent on an anti-TB drug?

BusinessLine Podcasts · BusinessLine

March 24, 20233m 41s

Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.